Compound Detail
CHEMBL4081711
ZIMLOVISERTIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL4081711 |
| Name | ZIMLOVISERTIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | JKDGKIBAOAFRPJ-ZBINZKHDSA-N |
4
Targets
29
Activities
1
Assay Types
15
PK Parameters
20
Publications
3
Known Names
5
Indications
1
Mechanisms
Molecular Properties
361.4
MW (Da)
1.58
ALogP
5
HBA
2
HBD
103.5
PSA (Ų)
0.81
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Interleukin-1 receptor-associated kinase 4 inhibitor | INHIBITOR | Interleukin-1 receptor-associated kinase 4 | ✓ | ✓ |
Indications
Arthritis, Rheumatoid Hidradenitis Suppurativa Severe Acute Respiratory Syndrome Lupus Erythematosus, Systemic Respiratory Distress Syndrome
Activity Summary
IC50 29 meas. best 10.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Interleukin-1 receptor-associated kinase 4 CHEMBL3778 | IC50 | 10.0 | 9.4886 | 0.1 | 21 |
| von Hippel-Lindau disease tumor suppressor/IRAK4 CHEMBL4523742 | IC50 | 7.8 | 7.55 | 15.8 | 6 |
| Casein kinase I isoform gamma-2 CHEMBL2543 | IC50 | 6.15 | 6.15 | 710.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 5.27 | 5.27 | 5330.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 25.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.056 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.01 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 0.01 | mL.min-1.kg-1 | Macaca fascicularis |
| F | 34.0 | % | Rattus norvegicus |
| F | 41.0 | % | Canis lupus familiaris |
| F | 6.9 | % | Macaca fascicularis |
| Fu | 0.3 | - | Rattus norvegicus |
| T1/2 | 0.6 | hr | Rattus norvegicus |
| T1/2 | 1.4 | hr | Rattus norvegicus |
| T1/2 | 1.1 | hr | Canis lupus familiaris |
| T1/2 | 4.0 | hr | Canis lupus familiaris |
| T1/2 | 1.7 | hr | Macaca fascicularis |
| T1/2 | 6.2 | hr | Macaca fascicularis |
| T1/2 | 2.8 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33091850 | 10.1016/j.bmc.2020.115815 | SUD4 | 30 |
| 33091850 | 10.1016/j.bmc.2020.115815 | OCI-Ly10 | 30 |
| - | 10.6019/CHEMBL5465560 | Ribosomal protein S6 kinase alpha-3 | 26 |
| - | 10.6019/CHEMBL5465560 | Ribosomal protein S6 kinase alpha-1 | 26 |
| - | 10.6019/CHEMBL5465560 | Serine/threonine-protein kinase MARK2 | 21 |
| - | 10.6019/CHEMBL5465560 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 17 |
| - | 10.6019/CHEMBL5465560 | Aurora kinase A | 16 |
| - | 10.6019/CHEMBL5465560 | MAP/microtubule affinity-regulating kinase 3 | 16 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase JAK1 | 16 |
| - | 10.6019/CHEMBL5465560 | Serine/threonine-protein kinase 10 | 15 |
| - | 10.6019/CHEMBL5465560 | Serine/threonine-protein kinase PRP4 homolog | 15 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase ABL1 | 14 |
| - | 10.6019/CHEMBL5465560 | Dual specificity mitogen-activated protein kinase kinase 1 | 13 |
| - | 10.6019/CHEMBL5465560 | Dual specificity mitogen-activated protein kinase kinase 6 | 13 |
| - | 10.6019/CHEMBL5465560 | Tyrosine-protein kinase Lyn | 12 |
| - | 10.6019/CHEMBL5465560 | Dual specificity mitogen-activated protein kinase kinase 2 | 12 |
| - | 10.6019/CHEMBL5465560 | Calcium/calmodulin-dependent protein kinase type 1D | 12 |
| - | 10.6019/CHEMBL5465560 | Calcium/calmodulin-dependent protein kinase type II subunit beta | 11 |
| - | 10.6019/CHEMBL5465560 | Calcium/calmodulin-dependent protein kinase type II subunit delta | 11 |
| - | 10.6019/CHEMBL5465560 | MAP/microtubule affinity-regulating kinase 4 | 11 |
Data from ChEMBL 36 via Core Engine